Suministro De La Demanda De Energía En El Procesamiento De Carne De Pollo Con Biogás

The main use of electrical energy in the chicken meat processing unit is refrigeration. About 70% of the electricity is consumed in the compressors for the refrigeration system. Through this study, the energetic viability of using biogas from poultry litter in supplying the demand for the refrigeration process was found. The meat processing unit studied has the potential to process about a hundred and sixty thousand chickens a day. The potential biogas production from poultry litter is 60,754,298.91 m3.year-1. There will be a surplus of approximately 8,103 MWh per month of electric energy generated from biogas. An economic analysis was performed considering a planning horizon of 20 years and the discount rate of 12% per year. The economic analysis was performed considering scenario 1: sale of all electricity generated by the thermoelectric facility, and scenario 2: sale of the surplus electricity generated after complying with the demands of the refrigeration process and all other electrical energy and thermal energy use. Economic indicators obtained for scenarios 1 and 2 were favorable for the project implementation. © 2016, Revista Ingenieria e Investigacion - Editorial Board. All Rights reserved.36111812

Longslit spectroscopy of the starburst galaxy HRG 02401

We investigate in detail the kinematics and morphology of the starburst galaxy HRG 02401. Our observational data were obtained at the 1.6-m OPD/LNA-MCT telescope with longslit spectroscopy. The original image has been enhanced to highlight some substructures and it has shown that HRG 02401 is in phase of active merging with a companion galaxy. The resulting tidal perturbations may have induced the apparent two-armed spiral pattern and driven a substantial fraction of disc gas inwards. We have been able to study the detailed picture of ionized gas motions up to galactocentric distances of 11 kpc and to construct the stellar velocity field for the inner region. Although the optical ring is quite narrow, H(alpha) emission is observed all the way through the center of the galaxy, indicating the presence of an extended gaseous disk. We have estimated nuclear redshift of z = 0.017, corresponding to a heliocentric velocity of 5,206 \pm 13.01 km s(-1). The errors in the  fluxes were mostly caused by uncertainties in the placement of the continuum level. Some other physical parameters have been derived whenever possible. All spectra were reduced and analyzed in a homogeneous way with the standard IRAF procedures

Longslit spectroscopy of the peculiar Seyfert 2 galaxy HRG 10103

We present the rst optical longslit spectroscopy for the galaxy HRG 10103, an Sa(r) type peculiar galaxy seen face-on with an asymmetrical elliptical structure. The main goal of this work is to provide the spectral classication of the current object using the `traditional' diagnostic diagrams. However, we also present a diagnostic involving the known emission line ratio R23, usually used to estimate the O/H abundance ratio. The idea is to make a better distinction between the narrow-line AGNs and the H II galaxies. The spectra were obtained in two observatories (OPD-LNA/MCT and Gemini-South) and includes some of the most important emission lines for ionization diagnostic. Based on the observed spectra, HRG 10103 is a Seyfert 2 galaxy with typical line-ratios values in the optical range. We have estimated nuclear redshift of z = 0.039. The resulting reddening values as a function of distance from the nucleus are presented too. The errors in the  fluxes were mostly caused by uncertainties in the placement of the continuum level. The rotation curve is typical of spiral disks, rising shallowly and  attening at an observed amplitude of about 200 km s^(-1). Some other physical parameters have been derived whenever possible. The spectroscopic data reduction was carried out using the GEMINI.GMOS package as well as the standard IRAF procedures

Bone Flap Management In Neurosurgery

Bone flap removal procedure is growing in frequency in neurosurgical practice. Decompressive craniotomy has gained more scientifical evidences of its therapeutical value in post-traumatic brain swelling, in cerebrovascular diseases and in brain edema non - responding to clinical treatment after elective surgeries. Bone flap destination after craniotomy has many possible fates. We present a literature review of bone flap management in neurosurgical practice: technical preservation of bone flaps (under the scalp, in the abdominal wall, frozen), when to remove the bone flap and what to do when it is dropped during the craniotomy or is infected.172133137Movassaghi, K., Ver Halen, J., Ganchi, P., Amin-Hanjani, S., Mesa, J., Yaremchuk, M.J., Cranioplasty with subcutaneously preserved autologous bone grafts (2006) Plast Reconstr Surg, 117 (1), pp. 202-206Hauptli, J., Segantini, P., New tissue preservation method for bone flaps following decompressive craniotomy (1980) Helv Chir Acta, 47 (1-2), pp. 121-124Tybor, K., Fortuniak, J., Komunski, P., Papiez, T., Andrzejak, S., Jaskólski, D., Supplementation of cranial defects by an autologous bone flap stored in the abdominal wall (2005) Neurol Neurochir Pol, 39 (3), pp. 220-224Josan, V.A., Sgouros, S., Walsh, A.R., Dover, M.S., Nishikawa, H., Hockley, A.D., Cranioplasty in children (2005) Childs Nerv Syst, 21 (3), pp. 200-204Flannery, T., McConnell, R.S., Cranioplasty: Why throw the bone flap out? (2001) Br J Neurosurg, 15 (6), pp. 518-520Krishnan, P., Bhattacharyya, A.K., Sil, K., De, R., Bone flap preservation after decompressive craniectomy - experience with 55 cases (2006) Neurol India, 54 (3), pp. 291-292Korfali, E., Aksoy, K., Preservation of craniotomy bone flaps under the scalp (1988) Surg Neurol, 30 (4), pp. 269-272Goel, A., Deogaonkar, M., Subgaleal preservation of calvarial flaps (1995) Surg Neurol, 44 (2), pp. 181-182. , Aug;, discussion 182-3Pasaoglu, A., Kurtsoy, A., Koc, R.K., Kontas, O., Akdemir, H., Öktem, I.S., Cranioplasty with bone flaps preserved under the scalp (1996) Neurosurg Rev, 19 (3), pp. 153-156Iwama, T., Yamada, J., Imai, S., Shinoda, J., Funakoshi, T., Sakai, N., The use of frozen autogenous bone flaps in delayed cranioplasty revisited (2003) Neurosurgery, 52 (3), pp. 591-596Winkler, P.A., Stummer, W., Linke, R., Krishnan, K.G., Tatsch, K., The influence of cranioplasty on postural blood flow regulation, cerebrovascular reserve capacity, and cerebral glucose metabolism (2000) Neurosurg Focus, 8 (1), pp. e9Matsuno, A., Tanaka, H., Iwamuro, H., Takanashi, S., Miyawaki, S., Nakashima, M., Analyses of the factors influencing bone graft infection after delayed cranioplasty (2006) Acta Neurochir (Wien), 148 (5), pp. 535-540Yacubian-Fernandes, A., Laronga, P.R., Coelho, R.A., Ducati, L.G., Silva, M.V., Prototyping as an alternative to cranioplasty using methylmethacrylate: Technical, 62 (3 B), pp. 865-868. , note. Arq Neuropsiquiatr 2004;Chiarini, L., Figurelli, S., Pollastri, G., Torcia, E., Ferrari, F., Albanese, M., Cranioplasty using acrylic material: A new technical procedure (2004) J Craniomaxillofac Surg, 32 (1), pp. 5-9Korinek, A.M., Risk factors for neurosurgical site infections after craniotomy: A prospective multicenter study of 2944 patients. The French Study Group of Neurosurgical Infections, the SEHP, and the C-CLIN Paris-Nord. Service Epidemiologie Hygiene et Prevention (1997) Neurosurgery, 41 (5), pp. 1073-1079Bruce, J.N., Bruce, S.S., Preservation of bone flaps in patients with postcraniotomy infections (2003) J Neurosurg, 98 (6), pp. 1203-1207Auguste, K.I., McDermott, M.W., Salvage of infected craniotomy bone flaps with the wash-in, wash-out indwelling antibiotic irrigation system. Technical note and case series of 12 patients (2006) J Neurosurg, 105 (4), pp. 640-644Jankowitz, B.T., Kondziolka, D.S., When the bone flap hits the floor (2006) Neurosurgery, 59 (3), pp. 585-59

GenSeed-HMM: A tool for progressive assembly using profile HMMs as seeds and its application in Alpavirinae viral discovery from metagenomic data

This work reports the development of GenSeed-HMM, a program that implements seed-driven progressive assembly, an approach to reconstruct specific sequences from unassembled data, starting from short nucleotide or protein seed sequences or profile Hidden Markov Models (HMM). The program can use any one of a number of sequence assemblers. Assembly is performed in multiple steps and relatively few reads are used in each cycle, consequently the program demands low computational resources. As a proof-of-concept and to demonstrate the power of HMM-driven progressive assemblies, GenSeed-HMM was applied to metagenomic datasets in the search for diverse ssDNA bacteriophages from the recently described Alpavirinae subfamily. Profile HMMs were built using Alpavirinae-specific regions from multiple sequence alignments using either the viral protein 1 (VP1) (major capsid protein) or VP4 (genome replication initiation protein). These profile HMMs were used by GenSeed-HMM (running Newbler assembler) as seeds to reconstruct viral genomes from sequencing datasets of human fecal samples. All contigs obtained were annotated and taxonomically classified using similarity searches and phylogenetic analyses. The most specific profile HMM seed enabled the reconstruction of 45 partial or complete Alpavirinae genomic sequences. A comparison with conventional (global) assembly of the same original dataset, using Newbler in a standalone execution, revealed that GenSeed-HMM outperformed global genomic assembly in several metrics employed. This approach is capable of detecting organisms that have not been used in the construction of the profile HMM, which opens up the possibility of diagnosing novel viruses, without previous specific information, constituting a de novo diagnosis. Additional applications include, but are not limited to, the specific assembly of extrachromosomal elements such as plastid and mitochondrial genomes from metagenomic data. Profile HMM seeds can also be used to reconstruct specific protein coding genes for gene diversity studies, and to determine all possible gene variants present in a metagenomic sample. Such surveys could be useful to detect the emergence of drug-resistance variants in sensitive environments such as hospitals and animal production facilities, where antibiotics are regularly used. Finally, GenSeed-HMM can be used as an adjunct for gap closure on assembly finishing projects, by using multiple contig ends as anchored seeds

General Relativistic Mean Field Theory for Rotating Nuclei

We formulate a general relativistic mean field theory for rotating nuclei starting from the special relativistic $\sigma - \omega$ model Lagrangian. The tetrad formalism is adopted to generalize the model to the accelerated frame.Comment: 13 pages, REVTeX, no figures, submitted to Phys. Rev. Lett., the word `curved' is replaced by `non-inertial' or `accelerated' in several places to clarify the physical situation interested, some references are added, more detail discussions are given with omitting some redundant sentence

Palaeontological framework from Pirabas Formation (North Brazil) used as potential model for equatorial carbonate platform

The Pirabas Formation (early to middle Miocene) from the equatorial margin of North Brazil is characterized by a shallow-marine carbonate platform with high fossil diversity and abundant micro- and macrofossil remains. The Pirabas Formation represents a unique carbonate system along the Atlantic margin of South America that developed before the onset of the Amazon delta. We studied the palaeontology and lithofacies of outcrops of the uppermost Pirabas Formation and found that was deposited in a coastal marine environment with marginal lagoons under the influence of a tidal regime and tropical storms. The remains of calcareous algae, molluscs, crustaceans, echinoiderms, bryozoans, solitary corals, fish and marine mammals, together with foraminifera, ostracods and other marine microfossils, shaped a biogenic framework, that together with the post-depositional processes of dissolution of skeletal grains, is responsible for the mean packstone-floatstone porosity of 14.9%. The palaeontological framework and the petrophysical characterization of the carbonate rocks from the uppermost Pirabas Formation outcrop represent a baseline to interpret the entire Pirabas Formation in the subsurface stratigraphic sections (cores) of this important Neogene unit. Considering that carbonate rocks account for ~50% of oil and gas reservoirs around the world, this research provides a model for Neogene tropical carbonate deposits useful for carbonate petroliferous reservoirs in the Brazilian equatorial basins.publishe

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme

BACKGROUND: Glufosfamide is a new alkylating agent in which the active metabolite of isophosphoramide mustard is covalently linked to beta-D-glucose to target the glucose transporter system and increase intracellular uptake in tumor cells. We investigated this drug in a multicenter prospective phase II trial in recurrent glioblastoma multiforme (GBM). PATIENTS AND METHODS: Eligible patients had recurrent GBM following surgery, radiotherapy and no more than one prior line of chemotherapy. Patients were treated with glufosfamide 5000 mg/m(2) administered as a 1-h intravenous infusion. Treatment success was defined as patients with either an objective response according to Macdonald's criteria or 6 months progression-free survival. Toxicity was assessed with the Common Toxicity Criteria (CTC) version 2.0. RESULTS: Thirty-one eligible patients were included. Toxicity was modest, the main clinically relevant toxicities being leukopenia (CTC grade >3 in five patients) and hepatotoxicity (in three patients). No responses were observed; one patient (3%; 95% confidence interval 0 to 17%) was free from progression at 6 months. Pharmacokinetic analysis showed a 15% decrease in area under the curve and glufosfamide clearance in patients treated with enzyme-inducing antiepileptic drugs, but no effect of these drugs on maximum concentration and plasma half-life. CONCLUSION: Glufosfamide did not show significant clinical antitumor activity in patients with recurrent GBM